via Firstpost Tech Latest News https://ift.tt/3vZKfMY
SEC recommends Bharat Biotech’s Covaxin phase 2, 3 clinical trials on 2- to 18-year-olds
Related Posts
Nobel Laureate, physicist Lev Landau's 111th birthday celebrated in a Google Doodle
Google faces $57 million fine from France for breaching EU online privacy rules
Honor View 20 to launch globally tomorrow: Here's what we know
New Motorola patent reveals 2019 Moto RAZR design with a foldable display
Google and other tech giants rejoice as EU copyright reform talks get stalled
0 comments: